Natural and Synthetic Cannabinoids Protected Brain Mitochondria From Toxic Damage

Anandamide and WIN 55212-2 protected isolated brain mitochondria from 3-NP toxicity by activating mitochondrial CB1 receptors.

Maya-López, Marisol et al.·Molecular neurobiology·2024·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-05531Animal StudyPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Both anandamide and WIN 55212-2 ameliorated 3-NP toxic effects on brain mitochondria. CB1 antagonist AM281 completely reversed protective effects, confirming mitochondrial CB1 receptor involvement.

Key Numbers

AEA and WIN 55212-2 ameliorated 3-NP effects. AM281 completely reversed all protective effects.

How They Did This

In vitro study using isolated rat brain mitochondria exposed to 3-NP. Outcomes: reduction capacity, ROS formation, mitochondrial swelling.

Why This Research Matters

Mitochondrial dysfunction is central to neurodegenerative diseases. CB1 receptors on mitochondria can be activated to protect them.

The Bigger Picture

Mitochondrial CB1 receptors are a relatively new discovery that could provide subcellular-level neuroprotection.

What This Study Doesn't Tell Us

In vitro isolated mitochondria. 3-NP model is specific. Direct translation to neurodegeneration is speculative.

Questions This Raises

  • ?Could mitochondrial CB1-targeted drugs provide neuroprotection without psychoactivity?
  • ?Is mitochondrial CB1 dysfunction involved in neurodegeneration?

Trust & Context

Key Stat:
Both anandamide and WIN 55212-2 protected mitochondria via CB1; antagonist fully reversed effects
Evidence Grade:
In vitro mitochondria study demonstrates mechanism but lacks cellular and in vivo context.
Study Age:
Published in 2024.
Original Title:
Anandamide and WIN 55212-2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study.
Published In:
Molecular neurobiology, 61(9), 6435-6452 (2024)
Database ID:
RTHC-05531

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can cannabinoids protect brain cells?

This study showed cannabinoids protected brain mitochondria from toxic damage via CB1 receptors on the mitochondrial membrane.

What are mitochondrial CB1 receptors?

CB1 receptors exist on mitochondria where they regulate energy production and protect against oxidative damage.

Read More on RethinkTHC

Cite This Study

RTHC-05531·https://rethinkthc.com/research/RTHC-05531

APA

Maya-López, Marisol; Monsalvo-Maraver, Luis Angel; Delgado-Arzate, Ana Laura; Olivera-Pérez, Carolina I; El-Hafidi, Mohammed; Silva-Palacios, Alejandro; Medina-Campos, Omar; Pedraza-Chaverri, José; Aschner, Michael; Tinkov, Alexey A; Túnez, Isaac; Retana-Márquez, Socorro; Zazueta, Cecilia; Santamaría, Abel. (2024). Anandamide and WIN 55212-2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study.. Molecular neurobiology, 61(9), 6435-6452. https://doi.org/10.1007/s12035-024-03967-2

MLA

Maya-López, Marisol, et al. "Anandamide and WIN 55212-2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study.." Molecular neurobiology, 2024. https://doi.org/10.1007/s12035-024-03967-2

RethinkTHC

RethinkTHC Research Database. "Anandamide and WIN 55212-2 Afford Protection in Rat Brain Mi..." RTHC-05531. Retrieved from https://rethinkthc.com/research/maya-lopez-2024-anandamide-and-win-552122

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.